204 related articles for article (PubMed ID: 38021429)
1. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast].
Hawkes JE; Reisner DV; Bhutani T
Clin Cosmet Investig Dermatol; 2023; 16():3333-3339. PubMed ID: 38021429
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
Song EJ; Liu C
Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast].
Merola JF; Amin AZ
Clin Cosmet Investig Dermatol; 2024; 17():539-545. PubMed ID: 38482176
[TBL] [Abstract][Full Text] [Related]
4. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
5. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast].
Bhutani T; Hawkes JE
Clin Cosmet Investig Dermatol; 2023; 16():1553-1558. PubMed ID: 37351064
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date.
Rega F; Trovato F; Bortone G; Pellacani G; Richetta AG; Dattola A
Psoriasis (Auckl); 2024; 14():23-27. PubMed ID: 38505140
[TBL] [Abstract][Full Text] [Related]
8. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
9. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
10. Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
Megna M; Camela E; Ruggiero A; Battista T; Martora F; Cacciapuoti S; Potestio L
Clin Cosmet Investig Dermatol; 2023; 16():1677-1690. PubMed ID: 37404368
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
Potestio L; Camela E; Cacciapuoti S; Martora F; Guerriero L; Fornaro L; Ruggiero A; Megna M
Expert Opin Drug Saf; 2023; 22(11):1003-1010. PubMed ID: 37768729
[TBL] [Abstract][Full Text] [Related]
14. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
15. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
Burden AD
Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
[TBL] [Abstract][Full Text] [Related]
16. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
Choon SE; Lebwohl MG; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Rajeswari S; Deng H; Tetzlaff K; Thoma C; Bachelez H
BMJ Open; 2021 Mar; 11(3):e043666. PubMed ID: 33785490
[TBL] [Abstract][Full Text] [Related]
17. Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
Strober B; Leman J; Mockenhaupt M; Nakano de Melo J; Nassar A; Prajapati VH; Romanelli P; Seneschal J; Tsianakas A; Wei LY; Yasuda M; Yu N; Hernandez Daly AC; Okubo Y
Dermatol Ther (Heidelb); 2022 Feb; 12(2):381-393. PubMed ID: 34904208
[TBL] [Abstract][Full Text] [Related]
18. Current management of generalized pustular psoriasis.
Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
[TBL] [Abstract][Full Text] [Related]
19. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
20. Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Anadkat MJ; Rajeswari S; Hua H; Vulcu SD; Hall D; Tetzlaff K; Thoma C; Lebwohl MG;
N Engl J Med; 2021 Dec; 385(26):2431-2440. PubMed ID: 34936739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]